SCLX
Scilex Holding Company
NASDAQ: SCLX · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$10.52
+21.76% today
Updated 2026-04-30
Market cap
$47.05M
P/E ratio
—
P/S ratio
1.56x
EPS (TTM)
$-36.48
Dividend yield
—
52W range
$4 – $34
Volume
0.0M
Scilex Holding Company (SCLX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-782.00%
ROE
0.00%
ROA
-74.30%
Debt/equity
-0.38x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $21.03M | $-178.59M | 72.41% | -659.42% | -849.11% |
| 2020 | $23.56M | $-47.52M | 90.88% | -149.65% | -201.69% |
| 2021 | $31.32M | $-88.42M | 88.40% | -114.44% | -282.35% |
| 2022 | $38.03M | $-23.36M | 71.61% | -133.13% | -61.43% |
| 2023 | $46.74M | $-114.33M | 66.45% | -225.55% | -244.59% |
| 2024 | $56.59M | $-72.81M | 70.51% | -147.37% | -128.66% |
| 2025 | $30.25M | $-358.73M | 49.68% | -900.09% | -1,185.78% |